/Companies

Superior Genomics

Norway, US · Founded 2023

Find your way into Superior Genomics

Sign up to see every warm intro you have to Superior Genomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Superior Genomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Superior Genomics is an early-stage health technology company developing diagnostic blood tests that distinguish depressive symptoms as either Bipolar Disorder or Major Depressive Disorder, based on gene expression bioprofiles found in blood. It aims to provide objective diagnostic tools for mental health disorders in clinical settings.

Founders & leadership

JP
John Prista FreshleyNamed on SEC filing
DV
David Van HollaDr.

Reported raises · per SEC filings

Form D private placements

$507.5K disclosed across 1 round · 2026

▶$507.5KraisedAug 2026 · 14 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Van HollaExecutive Officer, Director
  • John Prista FreshleyDirector
Offering amount
$1.5M
Amount sold
$507.5K
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Superior Genomics do?
Superior Genomics is an early-stage health technology company developing diagnostic blood tests that distinguish depressive symptoms as either Bipolar Disorder or Major Depressive Disorder, based on gene expression bioprofiles found in blood. It aims to provide objective diagnostic tools for mental health disorders in clinical settings.
How much funding has Superior Genomics raised?
Superior Genomics has disclosed $507.5K raised across 1 round.
Where is Superior Genomics headquartered?
Superior Genomics is headquartered in Norway, US.